Randomized controlled trial of rituximab and cost骵ffectiveness analysis in treating fatigue and oral dryness in primary Sjögren's syndrome

SJ Bowman, CC Everett, JL O'Dwyer… - Arthritis & …, 2017 - Wiley Online Library
Objective To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …
被引用次数：283 相关文章

Randomized Controlled Trial of Rituximab and Cost驟ffectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer, P Emery… - Arthritis & …, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Objective</jats: title>< jats: p> To investigate whether rituximab,
an anti–B cell therapy, improves symptoms of fatigue and oral dryness in patients with …
[PDF] academia.edu

[PDF][PDF] Randomized Controlled Trial of Rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's Syndrome

P Lanyon, RJ Rheumatology Moots - academia.edu
Objective: We investigated whether rituximab, an anti-B-cell therapy, improved symptoms of
fatigue and oral dryness in patients with Primary Sjögren's Syndrome (PSS). Methods …

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer, P Emery… - 2017 - pubmed.ncbi.nlm.nih.gov
Objective To investigate whether rituximab, an anti-B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome.

SJ Bowman, CC Everett… - Arthritis & …, 2017 - researchonline.lshtm.ac.uk
OBJECTIVE: To investigate whether rituximab, an anti-B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). METHODS: We …
[PDF] qmul.ac.uk

[PDF][PDF] Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjogren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer… - ARTHRITIS & …, 2017 - qmro.qmul.ac.uk
Objective: We investigated whether rituximab, an anti-B-cell therapy, improved symptoms of
fatigue and oral dryness in patients with Primary Sjögren's Syndrome (PSS). Methods …
[PDF] researchgate.net

[PDF][PDF] Randomized Controlled Trial of Rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjogren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer, P Emery… - researchgate.net
Objective: We investigated whether rituximab, an anti-B-cell therapy, improved symptoms of
fatigue and oral dryness in patients with Primary Sjögren's Syndrome (PSS). Methods …

Randomized controlled trial of rituximab and cost-effectiveness analysis in treating fatigue and oral dryness in primary Sjögren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer, P Emery… - sussex.figshare.com
Objective To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods We …

Randomized Controlled Trial of Rituximab and Cost-Effectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer… - Arthritis and …, 2017 - eprints.ncl.ac.uk
Abstract© 2017, American College of Rheumatology. Objective: To investigate whether
rituximab, an anti-B cell therapy, improves symptoms of fatigue and oral dryness in patients …

Randomized Controlled Trial of Rituximab and Cost驟ffectiveness Analysis in Treating Fatigue and Oral Dryness in Primary Sjögren's Syndrome

SJ Bowman, CC Everett, JL O'Dwyer… - Arthritis & …, 2017 - eprints.whiterose.ac.uk
Objective: To investigate whether rituximab, an anti–B cell therapy, improves symptoms of
fatigue and oral dryness in patients with primary Sjögren's syndrome (SS). Methods: We …